Clinical Trial Update: A Study of Tazemetostat With Enzalutamide or Abiraterone/Prednisone in Participants With Advanced Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluating tazemetostat in combination with enzalutamide or abiraterone/prednisone in advanced/metastatic prostate cancer was terminated, with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)
• Enzalutamide (enzalutamide)
• PREDNISONE (Prednisone)
• Tazemetostat (tazemetostat)

Snippet

Sponsor: Epizyme, Inc. | Conditions: Metastatic Prostate Cancer, Metastatic Castration-resistant Prostate Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2026-03-10